nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Everolimus—kidney cancer	0.155	0.293	CbGbCtD
Budesonide—CYP3A4—Temsirolimus—kidney cancer	0.105	0.198	CbGbCtD
Budesonide—CYP3A4—Pazopanib—kidney cancer	0.0549	0.104	CbGbCtD
Budesonide—CYP3A4—Erlotinib—kidney cancer	0.0392	0.0741	CbGbCtD
Budesonide—CYP3A4—Paclitaxel—kidney cancer	0.0359	0.0678	CbGbCtD
Budesonide—CYP3A4—Sorafenib—kidney cancer	0.0319	0.0603	CbGbCtD
Budesonide—CYP3A4—Vinblastine—kidney cancer	0.0315	0.0595	CbGbCtD
Budesonide—CYP3A4—Vincristine—kidney cancer	0.0309	0.0585	CbGbCtD
Budesonide—CYP3A4—Sunitinib—kidney cancer	0.0258	0.0488	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—kidney cancer	0.0193	0.0366	CbGbCtD
Budesonide—Amcinonide—ANXA1—kidney cancer	0.00293	0.364	CrCbGaD
Budesonide—NR3C1—urine—kidney cancer	0.00177	0.282	CbGeAlD
Budesonide—CYP3A4—urine—kidney cancer	0.00134	0.214	CbGeAlD
Budesonide—Hydrocortisone—ANXA1—kidney cancer	0.00123	0.154	CrCbGaD
Budesonide—Dexamethasone—ANXA1—kidney cancer	0.000919	0.114	CrCbGaD
Budesonide—Triamcinolone—BCHE—kidney cancer	0.000562	0.07	CrCbGaD
Budesonide—Clobetasol propionate—CYP1A1—kidney cancer	0.000528	0.0657	CrCbGaD
Budesonide—NR3C1—nephron tubule—kidney cancer	0.000476	0.076	CbGeAlD
Budesonide—NR3C1—renal system—kidney cancer	0.000433	0.0691	CbGeAlD
Budesonide—NR3C1—kidney—kidney cancer	0.000418	0.0668	CbGeAlD
Budesonide—NR3C1—cortex of kidney—kidney cancer	0.000407	0.0651	CbGeAlD
Budesonide—NR3C1—gonad—kidney cancer	0.000388	0.062	CbGeAlD
Budesonide—NR3C1—cardiac atrium—kidney cancer	0.000387	0.0619	CbGeAlD
Budesonide—CYP3A4—renal system—kidney cancer	0.000327	0.0523	CbGeAlD
Budesonide—CYP3A4—kidney—kidney cancer	0.000316	0.0505	CbGeAlD
Budesonide—Methylprednisolone—ABCB1—kidney cancer	0.000261	0.0325	CrCbGaD
Budesonide—Triamcinolone—PTGS2—kidney cancer	0.000259	0.0323	CrCbGaD
Budesonide—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000237	0.0471	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.000224	0.0446	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—kidney cancer	0.000212	0.0264	CrCbGaD
Budesonide—Nausea—Everolimus—kidney cancer	0.000207	0.000457	CcSEcCtD
Budesonide—Diarrhoea—Sorafenib—kidney cancer	0.000207	0.000457	CcSEcCtD
Budesonide—Hypertension—Paclitaxel—kidney cancer	0.000207	0.000457	CcSEcCtD
Budesonide—Pruritus—Sunitinib—kidney cancer	0.000206	0.000455	CcSEcCtD
Budesonide—Angiopathy—Capecitabine—kidney cancer	0.000205	0.000453	CcSEcCtD
Budesonide—Immune system disorder—Capecitabine—kidney cancer	0.000204	0.000451	CcSEcCtD
Budesonide—Arthralgia—Paclitaxel—kidney cancer	0.000204	0.000451	CcSEcCtD
Budesonide—Chest pain—Paclitaxel—kidney cancer	0.000204	0.000451	CcSEcCtD
Budesonide—Myalgia—Paclitaxel—kidney cancer	0.000204	0.000451	CcSEcCtD
Budesonide—Mediastinal disorder—Capecitabine—kidney cancer	0.000203	0.00045	CcSEcCtD
Budesonide—Anxiety—Paclitaxel—kidney cancer	0.000203	0.000449	CcSEcCtD
Budesonide—Face oedema—Doxorubicin—kidney cancer	0.000203	0.000449	CcSEcCtD
Budesonide—Decreased appetite—Gemcitabine—kidney cancer	0.000203	0.000449	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—kidney cancer	0.000203	0.000449	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000202	0.000448	CcSEcCtD
Budesonide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000201	0.000446	CcSEcCtD
Budesonide—Discomfort—Paclitaxel—kidney cancer	0.000201	0.000445	CcSEcCtD
Budesonide—Fatigue—Gemcitabine—kidney cancer	0.000201	0.000445	CcSEcCtD
Budesonide—Gastrointestinal pain—Vincristine—kidney cancer	0.000201	0.000445	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.0002	0.0398	CbGpPWpGaD
Budesonide—Prednisone—ABCB1—kidney cancer	0.0002	0.0249	CrCbGaD
Budesonide—Dizziness—Sorafenib—kidney cancer	0.0002	0.000442	CcSEcCtD
Budesonide—Pain—Gemcitabine—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Constipation—Gemcitabine—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Nausea—Erlotinib—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Alopecia—Capecitabine—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Dry mouth—Paclitaxel—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Mood swings—Doxorubicin—kidney cancer	0.000199	0.000441	CcSEcCtD
Budesonide—Diarrhoea—Sunitinib—kidney cancer	0.000199	0.00044	CcSEcCtD
Budesonide—Mental disorder—Capecitabine—kidney cancer	0.000198	0.000437	CcSEcCtD
Budesonide—Dexamethasone—CYP1A1—kidney cancer	0.000198	0.0246	CrCbGaD
Budesonide—Asthenia—Dactinomycin—kidney cancer	0.000197	0.000437	CcSEcCtD
Budesonide—Confusional state—Paclitaxel—kidney cancer	0.000197	0.000436	CcSEcCtD
Budesonide—Malnutrition—Capecitabine—kidney cancer	0.000196	0.000435	CcSEcCtD
Budesonide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000195	0.000432	CcSEcCtD
Budesonide—Abdominal pain—Vincristine—kidney cancer	0.000194	0.00043	CcSEcCtD
Budesonide—Body temperature increased—Vincristine—kidney cancer	0.000194	0.00043	CcSEcCtD
Budesonide—Infection—Paclitaxel—kidney cancer	0.000194	0.000429	CcSEcCtD
Budesonide—Flatulence—Capecitabine—kidney cancer	0.000193	0.000428	CcSEcCtD
Budesonide—Dysgeusia—Capecitabine—kidney cancer	0.000192	0.000426	CcSEcCtD
Budesonide—Dizziness—Sunitinib—kidney cancer	0.000192	0.000425	CcSEcCtD
Budesonide—Feeling abnormal—Gemcitabine—kidney cancer	0.000192	0.000425	CcSEcCtD
Budesonide—Shock—Paclitaxel—kidney cancer	0.000192	0.000425	CcSEcCtD
Budesonide—Vomiting—Sorafenib—kidney cancer	0.000192	0.000425	CcSEcCtD
Budesonide—Abdominal pain upper—Doxorubicin—kidney cancer	0.000192	0.000425	CcSEcCtD
Budesonide—Nervous system disorder—Paclitaxel—kidney cancer	0.000191	0.000424	CcSEcCtD
Budesonide—Hypokalaemia—Doxorubicin—kidney cancer	0.000191	0.000423	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.000191	0.038	CbGpPWpGaD
Budesonide—Tachycardia—Paclitaxel—kidney cancer	0.000191	0.000422	CcSEcCtD
Budesonide—Rash—Sorafenib—kidney cancer	0.00019	0.000422	CcSEcCtD
Budesonide—Dermatitis—Sorafenib—kidney cancer	0.00019	0.000421	CcSEcCtD
Budesonide—Back pain—Capecitabine—kidney cancer	0.00019	0.00042	CcSEcCtD
Budesonide—Breast disorder—Doxorubicin—kidney cancer	0.00019	0.00042	CcSEcCtD
Budesonide—Skin disorder—Paclitaxel—kidney cancer	0.00019	0.00042	CcSEcCtD
Budesonide—Headache—Sorafenib—kidney cancer	0.000189	0.000419	CcSEcCtD
Budesonide—Muscle spasms—Capecitabine—kidney cancer	0.000189	0.000418	CcSEcCtD
Budesonide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000189	0.000418	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—kidney cancer	0.000188	0.000417	CcSEcCtD
Budesonide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000188	0.000416	CcSEcCtD
Budesonide—Anorexia—Paclitaxel—kidney cancer	0.000186	0.000412	CcSEcCtD
Budesonide—Vision blurred—Capecitabine—kidney cancer	0.000185	0.00041	CcSEcCtD
Budesonide—Vomiting—Sunitinib—kidney cancer	0.000185	0.000409	CcSEcCtD
Budesonide—Body temperature increased—Gemcitabine—kidney cancer	0.000184	0.000408	CcSEcCtD
Budesonide—Prednisolone—ABCB1—kidney cancer	0.000184	0.0229	CrCbGaD
Budesonide—Tremor—Capecitabine—kidney cancer	0.000184	0.000407	CcSEcCtD
Budesonide—Rash—Sunitinib—kidney cancer	0.000183	0.000406	CcSEcCtD
Budesonide—Dermatitis—Sunitinib—kidney cancer	0.000183	0.000405	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—kidney cancer	0.000183	0.000405	CcSEcCtD
Budesonide—Ill-defined disorder—Capecitabine—kidney cancer	0.000182	0.000403	CcSEcCtD
Budesonide—Headache—Sunitinib—kidney cancer	0.000182	0.000403	CcSEcCtD
Budesonide—Influenza—Doxorubicin—kidney cancer	0.000182	0.000402	CcSEcCtD
Budesonide—Anaemia—Capecitabine—kidney cancer	0.000181	0.000402	CcSEcCtD
Budesonide—Hypersensitivity—Vincristine—kidney cancer	0.000181	0.000401	CcSEcCtD
Budesonide—Betamethasone—ABCB1—kidney cancer	0.00018	0.0225	CrCbGaD
Budesonide—Nausea—Sorafenib—kidney cancer	0.000179	0.000397	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000178	0.000394	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.000178	0.0353	CbGpPWpGaD
Budesonide—Malaise—Capecitabine—kidney cancer	0.000177	0.000392	CcSEcCtD
Budesonide—Insomnia—Paclitaxel—kidney cancer	0.000177	0.000391	CcSEcCtD
Budesonide—Vertigo—Capecitabine—kidney cancer	0.000176	0.00039	CcSEcCtD
Budesonide—Asthenia—Vincristine—kidney cancer	0.000176	0.00039	CcSEcCtD
Budesonide—Syncope—Capecitabine—kidney cancer	0.000176	0.00039	CcSEcCtD
Budesonide—Paraesthesia—Paclitaxel—kidney cancer	0.000175	0.000388	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—kidney cancer	0.000175	0.000387	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—kidney cancer	0.000175	0.000387	CcSEcCtD
Budesonide—Dyspnoea—Paclitaxel—kidney cancer	0.000174	0.000385	CcSEcCtD
Budesonide—Somnolence—Paclitaxel—kidney cancer	0.000174	0.000384	CcSEcCtD
Budesonide—Palpitations—Capecitabine—kidney cancer	0.000174	0.000384	CcSEcCtD
Budesonide—Rash—Dactinomycin—kidney cancer	0.000173	0.000384	CcSEcCtD
Budesonide—Nausea—Sunitinib—kidney cancer	0.000173	0.000382	CcSEcCtD
Budesonide—Loss of consciousness—Capecitabine—kidney cancer	0.000173	0.000382	CcSEcCtD
Budesonide—Dyspepsia—Paclitaxel—kidney cancer	0.000172	0.00038	CcSEcCtD
Budesonide—Cough—Capecitabine—kidney cancer	0.000171	0.000379	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—kidney cancer	0.00017	0.000376	CcSEcCtD
Budesonide—Decreased appetite—Paclitaxel—kidney cancer	0.00017	0.000376	CcSEcCtD
Budesonide—Hypertension—Capecitabine—kidney cancer	0.00017	0.000375	CcSEcCtD
Budesonide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000169	0.000373	CcSEcCtD
Budesonide—Fatigue—Paclitaxel—kidney cancer	0.000168	0.000373	CcSEcCtD
Budesonide—Diarrhoea—Vincristine—kidney cancer	0.000168	0.000372	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—kidney cancer	0.000168	0.000371	CcSEcCtD
Budesonide—Asthenia—Gemcitabine—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Arthralgia—Capecitabine—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Chest pain—Capecitabine—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Myalgia—Capecitabine—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Pain—Paclitaxel—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Constipation—Paclitaxel—kidney cancer	0.000167	0.00037	CcSEcCtD
Budesonide—Anxiety—Capecitabine—kidney cancer	0.000167	0.000369	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000166	0.000367	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—kidney cancer	0.000165	0.000366	CcSEcCtD
Budesonide—Discomfort—Capecitabine—kidney cancer	0.000165	0.000366	CcSEcCtD
Budesonide—Pruritus—Gemcitabine—kidney cancer	0.000165	0.000365	CcSEcCtD
Budesonide—Dry mouth—Capecitabine—kidney cancer	0.000163	0.000362	CcSEcCtD
Budesonide—Nausea—Dactinomycin—kidney cancer	0.000163	0.000362	CcSEcCtD
Budesonide—Dizziness—Vincristine—kidney cancer	0.000163	0.00036	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000162	0.0322	CbGpPWpGaD
Budesonide—Infestation NOS—Doxorubicin—kidney cancer	0.000162	0.000358	CcSEcCtD
Budesonide—Infestation—Doxorubicin—kidney cancer	0.000162	0.000358	CcSEcCtD
Budesonide—Confusional state—Capecitabine—kidney cancer	0.000162	0.000358	CcSEcCtD
Budesonide—Feeling abnormal—Paclitaxel—kidney cancer	0.000161	0.000356	CcSEcCtD
Budesonide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00016	0.000353	CcSEcCtD
Budesonide—Diarrhoea—Gemcitabine—kidney cancer	0.00016	0.000353	CcSEcCtD
Budesonide—Infection—Capecitabine—kidney cancer	0.000159	0.000352	CcSEcCtD
Budesonide—Shock—Capecitabine—kidney cancer	0.000158	0.000349	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—kidney cancer	0.000157	0.000348	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—kidney cancer	0.000157	0.000348	CcSEcCtD
Budesonide—Nervous system disorder—Capecitabine—kidney cancer	0.000157	0.000348	CcSEcCtD
Budesonide—Tachycardia—Capecitabine—kidney cancer	0.000156	0.000346	CcSEcCtD
Budesonide—Vomiting—Vincristine—kidney cancer	0.000156	0.000346	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000156	0.0311	CbGpPWpGaD
Budesonide—Skin disorder—Capecitabine—kidney cancer	0.000156	0.000344	CcSEcCtD
Budesonide—Urticaria—Paclitaxel—kidney cancer	0.000155	0.000343	CcSEcCtD
Budesonide—Rash—Vincristine—kidney cancer	0.000155	0.000343	CcSEcCtD
Budesonide—Hyperhidrosis—Capecitabine—kidney cancer	0.000155	0.000343	CcSEcCtD
Budesonide—Dermatitis—Vincristine—kidney cancer	0.000155	0.000343	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—kidney cancer	0.000154	0.000342	CcSEcCtD
Budesonide—Body temperature increased—Paclitaxel—kidney cancer	0.000154	0.000342	CcSEcCtD
Budesonide—Abdominal pain—Paclitaxel—kidney cancer	0.000154	0.000342	CcSEcCtD
Budesonide—Headache—Vincristine—kidney cancer	0.000154	0.000341	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—kidney cancer	0.000153	0.000338	CcSEcCtD
Budesonide—Anorexia—Capecitabine—kidney cancer	0.000153	0.000338	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—kidney cancer	0.000152	0.000336	CcSEcCtD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000149	0.0296	CbGpPWpGaD
Budesonide—Vomiting—Gemcitabine—kidney cancer	0.000148	0.000328	CcSEcCtD
Budesonide—Rash—Gemcitabine—kidney cancer	0.000147	0.000325	CcSEcCtD
Budesonide—Dermatitis—Gemcitabine—kidney cancer	0.000147	0.000325	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—kidney cancer	0.000146	0.000323	CcSEcCtD
Budesonide—Headache—Gemcitabine—kidney cancer	0.000146	0.000323	CcSEcCtD
Budesonide—Nausea—Vincristine—kidney cancer	0.000146	0.000323	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000146	0.000323	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—kidney cancer	0.000146	0.000323	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—kidney cancer	0.000145	0.000322	CcSEcCtD
Budesonide—Insomnia—Capecitabine—kidney cancer	0.000145	0.000321	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—kidney cancer	0.000144	0.000319	CcSEcCtD
Budesonide—Paraesthesia—Capecitabine—kidney cancer	0.000144	0.000318	CcSEcCtD
Budesonide—Hypersensitivity—Paclitaxel—kidney cancer	0.000144	0.000318	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000144	0.000318	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—kidney cancer	0.000143	0.000317	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—kidney cancer	0.000143	0.000316	CcSEcCtD
Budesonide—Dyspnoea—Capecitabine—kidney cancer	0.000143	0.000316	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—kidney cancer	0.000143	0.000315	CcSEcCtD
Budesonide—Dyspepsia—Capecitabine—kidney cancer	0.000141	0.000312	CcSEcCtD
Budesonide—Hydrocortisone—ABCB1—kidney cancer	0.000141	0.0175	CrCbGaD
Budesonide—Visual impairment—Doxorubicin—kidney cancer	0.00014	0.00031	CcSEcCtD
Budesonide—Asthenia—Paclitaxel—kidney cancer	0.00014	0.00031	CcSEcCtD
Budesonide—Decreased appetite—Capecitabine—kidney cancer	0.000139	0.000308	CcSEcCtD
Budesonide—Nausea—Gemcitabine—kidney cancer	0.000139	0.000307	CcSEcCtD
Budesonide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000138	0.000306	CcSEcCtD
Budesonide—Fatigue—Capecitabine—kidney cancer	0.000138	0.000306	CcSEcCtD
Budesonide—Pruritus—Paclitaxel—kidney cancer	0.000138	0.000306	CcSEcCtD
Budesonide—Constipation—Capecitabine—kidney cancer	0.000137	0.000303	CcSEcCtD
Budesonide—Pain—Capecitabine—kidney cancer	0.000137	0.000303	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—kidney cancer	0.000136	0.000301	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—kidney cancer	0.000135	0.000299	CcSEcCtD
Budesonide—Flushing—Doxorubicin—kidney cancer	0.000135	0.000299	CcSEcCtD
Budesonide—Diarrhoea—Paclitaxel—kidney cancer	0.000134	0.000296	CcSEcCtD
Budesonide—Feeling abnormal—Capecitabine—kidney cancer	0.000132	0.000292	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—kidney cancer	0.000132	0.000292	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—kidney cancer	0.000131	0.000291	CcSEcCtD
Budesonide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000131	0.00029	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—kidney cancer	0.000131	0.00029	CcSEcCtD
Budesonide—Dizziness—Paclitaxel—kidney cancer	0.000129	0.000286	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—kidney cancer	0.000128	0.000284	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—kidney cancer	0.000127	0.000282	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000127	0.0253	CbGpPWpGaD
Budesonide—Urticaria—Capecitabine—kidney cancer	0.000127	0.000282	CcSEcCtD
Budesonide—Body temperature increased—Capecitabine—kidney cancer	0.000127	0.00028	CcSEcCtD
Budesonide—Abdominal pain—Capecitabine—kidney cancer	0.000127	0.00028	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—kidney cancer	0.000127	0.00028	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—kidney cancer	0.000125	0.000276	CcSEcCtD
Budesonide—Tension—Doxorubicin—kidney cancer	0.000124	0.000275	CcSEcCtD
Budesonide—Vomiting—Paclitaxel—kidney cancer	0.000124	0.000275	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—kidney cancer	0.000124	0.000274	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—kidney cancer	0.000123	0.0154	CrCbGaD
Budesonide—Rash—Paclitaxel—kidney cancer	0.000123	0.000272	CcSEcCtD
Budesonide—Dermatitis—Paclitaxel—kidney cancer	0.000123	0.000272	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—kidney cancer	0.000123	0.000272	CcSEcCtD
Budesonide—Back pain—Doxorubicin—kidney cancer	0.000122	0.000271	CcSEcCtD
Budesonide—Headache—Paclitaxel—kidney cancer	0.000122	0.000271	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—kidney cancer	0.000122	0.000269	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—kidney cancer	0.000119	0.000264	CcSEcCtD
Budesonide—Hypersensitivity—Capecitabine—kidney cancer	0.000118	0.000261	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000117	0.00026	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—kidney cancer	0.000117	0.000259	CcSEcCtD
Budesonide—Agitation—Doxorubicin—kidney cancer	0.000116	0.000257	CcSEcCtD
Budesonide—Nausea—Paclitaxel—kidney cancer	0.000116	0.000257	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.000115	0.0229	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.000115	0.0229	CbGpPWpGaD
Budesonide—Asthenia—Capecitabine—kidney cancer	0.000115	0.000254	CcSEcCtD
Budesonide—Malaise—Doxorubicin—kidney cancer	0.000114	0.000253	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—kidney cancer	0.000114	0.000252	CcSEcCtD
Budesonide—Syncope—Doxorubicin—kidney cancer	0.000113	0.000251	CcSEcCtD
Budesonide—Pruritus—Capecitabine—kidney cancer	0.000113	0.000251	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—kidney cancer	0.000112	0.000248	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—kidney cancer	0.000111	0.000246	CcSEcCtD
Budesonide—Cough—Doxorubicin—kidney cancer	0.00011	0.000244	CcSEcCtD
Budesonide—Diarrhoea—Capecitabine—kidney cancer	0.00011	0.000243	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—kidney cancer	0.000109	0.000242	CcSEcCtD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000108	0.0215	CbGpPWpGaD
Budesonide—Arthralgia—Doxorubicin—kidney cancer	0.000108	0.000238	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—kidney cancer	0.000108	0.000238	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—kidney cancer	0.000108	0.000238	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—kidney cancer	0.000107	0.000238	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000107	0.000237	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—kidney cancer	0.000106	0.000236	CcSEcCtD
Budesonide—Dizziness—Capecitabine—kidney cancer	0.000106	0.000235	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—kidney cancer	0.000105	0.000233	CcSEcCtD
Budesonide—Dexamethasone—ABCB1—kidney cancer	0.000105	0.0131	CrCbGaD
Budesonide—Confusional state—Doxorubicin—kidney cancer	0.000104	0.000231	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000103	0.000229	CcSEcCtD
Budesonide—Infection—Doxorubicin—kidney cancer	0.000103	0.000227	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.000102	0.0204	CbGpPWpGaD
Budesonide—Vomiting—Capecitabine—kidney cancer	0.000102	0.000225	CcSEcCtD
Budesonide—Shock—Doxorubicin—kidney cancer	0.000102	0.000225	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—kidney cancer	0.000101	0.000224	CcSEcCtD
Budesonide—Rash—Capecitabine—kidney cancer	0.000101	0.000224	CcSEcCtD
Budesonide—Dermatitis—Capecitabine—kidney cancer	0.000101	0.000223	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—kidney cancer	0.000101	0.000223	CcSEcCtD
Budesonide—Headache—Capecitabine—kidney cancer	0.0001	0.000222	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—kidney cancer	0.0001	0.000222	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—kidney cancer	9.99e-05	0.000221	CcSEcCtD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	9.98e-05	0.0199	CbGpPWpGaD
Budesonide—Anorexia—Doxorubicin—kidney cancer	9.85e-05	0.000218	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	9.83e-05	0.0196	CbGpPWpGaD
Budesonide—Nausea—Capecitabine—kidney cancer	9.52e-05	0.000211	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.41e-05	0.000208	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—kidney cancer	9.34e-05	0.000207	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—kidney cancer	9.27e-05	0.000205	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—kidney cancer	9.21e-05	0.000204	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—kidney cancer	9.18e-05	0.000203	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—kidney cancer	9.09e-05	0.000201	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—kidney cancer	8.98e-05	0.000199	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.92e-05	0.000197	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—kidney cancer	8.9e-05	0.000197	CcSEcCtD
Budesonide—Pain—Doxorubicin—kidney cancer	8.83e-05	0.000195	CcSEcCtD
Budesonide—Constipation—Doxorubicin—kidney cancer	8.83e-05	0.000195	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—kidney cancer	8.51e-05	0.000188	CcSEcCtD
Budesonide—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	8.47e-05	0.0169	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Doxorubicin—kidney cancer	8.45e-05	0.000187	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—HNF1A—kidney cancer	8.41e-05	0.0167	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—EPAS1—kidney cancer	8.41e-05	0.0167	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	8.36e-05	0.0166	CbGpPWpGaD
Budesonide—Urticaria—Doxorubicin—kidney cancer	8.21e-05	0.000182	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—kidney cancer	8.17e-05	0.000181	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—kidney cancer	8.17e-05	0.000181	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	7.82e-05	0.0156	CbGpPWpGaD
Budesonide—Hypersensitivity—Doxorubicin—kidney cancer	7.61e-05	0.000168	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—kidney cancer	7.41e-05	0.000164	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—kidney cancer	7.31e-05	0.000162	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	7.27e-05	0.0145	CbGpPWpGaD
Budesonide—Diarrhoea—Doxorubicin—kidney cancer	7.07e-05	0.000156	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—kidney cancer	6.83e-05	0.000151	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	6.69e-05	0.0133	CbGpPWpGaD
Budesonide—Vomiting—Doxorubicin—kidney cancer	6.57e-05	0.000145	CcSEcCtD
Budesonide—Rash—Doxorubicin—kidney cancer	6.51e-05	0.000144	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—kidney cancer	6.51e-05	0.000144	CcSEcCtD
Budesonide—Headache—Doxorubicin—kidney cancer	6.47e-05	0.000143	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	6.39e-05	0.0127	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	6.26e-05	0.0125	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	6.16e-05	0.0123	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—kidney cancer	6.14e-05	0.000136	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	5.86e-05	0.0117	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	5.51e-05	0.011	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	5.46e-05	0.0109	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—HIF1A—kidney cancer	5.28e-05	0.0105	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	5.28e-05	0.0105	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	5.18e-05	0.0103	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	5.07e-05	0.0101	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	4.84e-05	0.00964	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	4.8e-05	0.00956	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—APC—kidney cancer	4.6e-05	0.00915	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	4.41e-05	0.00878	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	4.35e-05	0.00866	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	4.35e-05	0.00865	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	4.25e-05	0.00845	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	4.19e-05	0.00833	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—ACY1—kidney cancer	4.06e-05	0.00808	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—APC—kidney cancer	3.92e-05	0.00781	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	3.3e-05	0.00656	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	3.29e-05	0.00655	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	3.28e-05	0.00653	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	3.22e-05	0.0064	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	3.14e-05	0.00624	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	3.11e-05	0.0062	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	2.76e-05	0.00549	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	2.7e-05	0.00537	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HARS—kidney cancer	2.7e-05	0.00537	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	2.67e-05	0.00531	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—HIF1A—kidney cancer	2.65e-05	0.00528	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	2.64e-05	0.00525	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	2.63e-05	0.00523	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	2.62e-05	0.00522	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	2.61e-05	0.00518	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	2.54e-05	0.00505	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	2.38e-05	0.00473	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	2.34e-05	0.00465	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	2.31e-05	0.0046	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.31e-05	0.00459	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF5B—kidney cancer	2.29e-05	0.00457	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	2.29e-05	0.00456	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	2.27e-05	0.00451	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	2.22e-05	0.00443	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	2.11e-05	0.0042	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	1.91e-05	0.0038	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	1.88e-05	0.00374	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.83e-05	0.00365	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	1.82e-05	0.00362	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.81e-05	0.0036	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	1.73e-05	0.00345	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CTNNB1—kidney cancer	1.59e-05	0.00316	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	1.53e-05	0.00304	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	1.49e-05	0.00296	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.49e-05	0.00296	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EEF2—kidney cancer	1.48e-05	0.00294	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TET2—kidney cancer	1.42e-05	0.00282	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	1.38e-05	0.00275	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	1.37e-05	0.00273	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.37e-05	0.00272	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.31e-05	0.0026	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TCEB1—kidney cancer	1.3e-05	0.00258	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TCEB2—kidney cancer	1.3e-05	0.00258	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.22e-05	0.00244	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	1.21e-05	0.00241	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	1.21e-05	0.0024	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.11e-05	0.0022	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL14—kidney cancer	1.05e-05	0.0021	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	9.06e-06	0.0018	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.94e-06	0.00178	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPB1—kidney cancer	8.59e-06	0.00171	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	8.59e-06	0.00171	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	8.33e-06	0.00166	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	8.21e-06	0.00163	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PSMD7—kidney cancer	7.98e-06	0.00159	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.89e-06	0.00157	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.79e-06	0.00155	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—JUNB—kidney cancer	7.17e-06	0.00143	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACY1—kidney cancer	6.94e-06	0.00138	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PDHB—kidney cancer	5.9e-06	0.00117	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—kidney cancer	5.89e-06	0.00117	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CDKN2B—kidney cancer	5.83e-06	0.00116	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CCBL1—kidney cancer	5.55e-06	0.0011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPAT—kidney cancer	4.81e-06	0.000958	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.81e-06	0.000958	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	4.7e-06	0.000934	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FH—kidney cancer	4.47e-06	0.00089	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APRT—kidney cancer	4.47e-06	0.00089	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPC3—kidney cancer	4.21e-06	0.000837	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA2—kidney cancer	4.09e-06	0.000814	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALAD—kidney cancer	3.99e-06	0.000794	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.89e-06	0.000775	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.8e-06	0.000757	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGK1—kidney cancer	3.65e-06	0.000726	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.65e-06	0.000726	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LDHB—kidney cancer	3.58e-06	0.000712	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA9—kidney cancer	3.1e-06	0.000617	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CRABP1—kidney cancer	2.64e-06	0.000525	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ITPR2—kidney cancer	2.45e-06	0.000488	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—kidney cancer	2.32e-06	0.000463	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—kidney cancer	2.26e-06	0.00045	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—kidney cancer	2.24e-06	0.000445	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACHE—kidney cancer	2.24e-06	0.000445	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SCARB1—kidney cancer	2.12e-06	0.000421	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS1—kidney cancer	2.09e-06	0.000417	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PSMD7—kidney cancer	2.05e-06	0.000409	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BCHE—kidney cancer	1.95e-06	0.000388	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.92e-06	0.000383	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.86e-06	0.00037	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—kidney cancer	1.55e-06	0.000308	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—kidney cancer	1.47e-06	0.000292	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—kidney cancer	1.42e-06	0.000283	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.35e-06	0.000269	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—kidney cancer	1.01e-06	0.0002	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—kidney cancer	8.03e-07	0.00016	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—kidney cancer	7e-07	0.000139	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.94e-07	9.83e-05	CbGpPWpGaD
